The National Centre for Infectious Diseases, previously known as the Communicable Disease Centre, is a national public health institute under the Ministry of Health of Singapore.

There are 330 (500 during outbreaks) beds in National Centre for Infectious Diseases, Tan Tock Seng Hospital.

During the past decade, National Centre for Infectious Diseases, Tan Tock Seng Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "National Centre for Infectious Diseases, Tan Tock Seng Hospital" are "COVID-19" (2 trials). Many other conditions were trialed in "National Centre for Infectious Diseases, Tan Tock Seng Hospital" in a lesser frequency.

Most popular intervention types in "National Centre for Infectious Diseases, Tan Tock Seng Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Remdesivir" (2 trials) and "Standard of Care" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Centre for Infectious Diseases, Tan Tock Seng Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "National Centre for Infectious Diseases, Tan Tock Seng Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in National Centre for Infectious Diseases, Tan Tock Seng Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Centre for Infectious Diseases, Tan Tock Seng Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".